Lung Transplant Week

HomePatientsLung Disease Week at the ATS2020Lung Transplant Week ▶ Information for Experts
Information for Experts

lungt

 

ClinicianATS Educational Products

INTERSTITIAL LUNG DISEASE: CURRENT TRENDS IN DIAGNOSIS AND MANAGEMENT

THE CUTTING EDGE IN LUNG TRANSPLANTATION

WHEN THERE IS NO RIGHT ANSWER: A PRO/CON DEBATE ON CONTROVERSIES IN ILD

THE CUTTING EDGE IN LUNG TRANSPLANTATION


ATS Journals on Lung Transplant

AJRCCM

Risk Factors for Acute Rejection in the First Year after Lung Transplant. A Multicenter Study
2020
Link to Abstract

Effect of Lung-Protective Ventilation in Organ Donors on Lung Procurement and Recipient Survival
2020
Link to Abstract

Interventional Bronchoscopy
2020
Link to Abstract

Mindfulness for those with COPD, Asthma, Lung Cancer and Lung Transplantation
2020
Link to Abstract

Pre-Procurement In Situ Donor Lung Tissue Gene Expression Classifies Primary Graft Dysfunction Risk
2020
Link to Abstract

Localization of Macrophages in the Human Lung via Design-based Stereology
2020
Link to Abstract

Pediatric Lung Transplant: Influences of Viral and Fungal Infections on Outcomes and Viral Markers as a Predictor of Outcome
2020
Link to Abstract

Endobronchial Post-transplant Lymphoproliferative Disease in a Child
2020
Link to Abstract

Respiratory Failure Due to Rapidly Progressive Metastatic Lung Calcifications after Heart Transplantation in a 6-Year-Old Girl
2019
Link to Abstract

First-Onset Herpesviral Infection and Lung Injury in Allogeneic Hematopoietic Cell Transplantation
2020
Link to Abstract

 

ANNALS

Recipient Age Impacts Long-Term Survival in Adult Cystic Fibrosis Subjects after Lung Transplantation
2020
Link to Abstract

Impact of Socioeconomic Position on Access to the US Lung Transplant Waiting List in a Matched Cystic Fibrosis Cohort
2020
Link to Abstract

Thoracic Visceral Adipose Tissue Area and Pulmonary Hypertension in Lung Transplant Candidates: The Lung Transplant Body Composition Study
2020
Link to Abstract

Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry
2020
Link to Abstract

Upper Respiratory Dysbiosis with a Facultative-dominated Ecotype in Advanced Lung Disease and Dynamic Change after Lung Transplant
2019
Link to Abstract

Clinical Outcomes of Lung Transplantation in the Presence of Donor-Specific Antibodies
2019
Link to Abstract

Association between Allosensitization and Waiting List Outcomes among Adult Lung Transplant Candidates in the United States
2019
Link to Abstract

Donor Lung Sequence Number and Survival after Lung Transplantation in the United States
2019
Link to Abstract

Procedure Preference and Intention-to-Treat Outcomes after Listing for Lung Transplantation among U.S. Adults. A Cohort Study
2019
Link to Abstract

 

AJRCMB

High CO2 Levels Impair Lung Wound Healing
2020
Link to Abstract

Nasal Wash Cytokines During Respiratory Viral Infection in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients
2020
Link to Abstract

Mitochondrial DNA Stimulates TLR9-Dependent Neutrophil Extracellular Trap Formation in Primary Graft Dysfunction
2020
Link to Abstract

Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the Endothelial-to-Mesenchymal Transition
2020
Link to Abstract

Trametinib Attenuates Delayed Rejection and Preserves Thymic Function in Rat Lung Transplantation
2019
Link to Abstract

Prolonged Cold Ischemia Induces Necroptotic Cell Death in Ischemia–Reperfusion Injury and Contributes to Primary Graft Dysfunction after Lung Transplantation
2019
Link to Abstract

Emphysema-associated Autoreactive Antibodies Exacerbate Post–Lung Transplant Ischemia–Reperfusion Injury
2019
Link to Abstract


 

ClinicianATS Statements, Guidelines and Reports

ATS Statements, Guidelines and Reports are printed in the American Journal of Respiratory and Critical Care Medicine. These documents are also available in PDF format. You may download one copy of any ATS document; there is no charge for this service. See lung transplant documents below:

An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome

  •